Literature DB >> 8320629

Inhalational nitric oxide: a selective pulmonary vasodilator for treatment of persistent pulmonary hypertension of the newborn.

R L Geggel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8320629     DOI： 10.1016/s0022-3476(05)81540-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  3 in total

1.  Elevated levels of asymmetric di-methylarginine in neonates with congenital diaphragmatic hernia.

Authors:  Christine M Pierce; Steven Krywawych; Andy J Petros
Journal:  Eur J Pediatr       Date:  2005-02-15       Impact factor: 3.183

2.  Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn.

Authors:  W Muller; W Kachel; P Lasch; V Varnholt; S A Konig
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

Review 3.  Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn.

Authors:  Giuseppe Distefano; Pietro Sciacca
Journal:  Ital J Pediatr       Date:  2015-02-08       Impact factor: 2.638
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.